IGFBP5 and diabetic kidney disease: Since several studies performed so far have demonstrated the diverse effects of IGFBP5 in the regulation of cell function, our data implied that IGFBP5 might perform as an important therapeutic agent for disorders in humans, including diabetic nephropathy and CLI.